Median Age (years, range) | 74 (59–82) |
Gleason Score n (%) | |
Low risk (≤6) | 5 (33.3) |
Intermediate risk (7) | 4 (26.7) |
High risk (>7) | 6 (40.0) |
Serum PSA (ng/ml) n (%) | |
Low risk (≤10) | 7 (46.7) |
Intermediate risk (10–20) | 3 (20.0) |
High risk (>20) | 5 (33.3) |
Initial tumor stage (clinical examination and CT/MRI), n (%) | |
Biopsy T1c | 7 (46.7) |
Intermediate risk (T2b) | 1 (6.7) |
High risk (≥T2c) | 7 (46.7) |